Manik Chatterjee

4.2k citations

87 papers · 2.7k indexed · h-index 32

Impact in

Hematology top 1%
- Multiple Myeloma Research and Treatments
Oncology top 5%
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research

Papers in ⓘ

Hematology 38
- Multiple Myeloma Research and Treatments 38
Oncology 26
- Peptidase Inhibition and Analysis 6

Co-authors: Ralf C. Bargou (45 shared papers)Thorsten Stühmer (28 shared papers)Hermann Einsele (30 shared papers)Kurt Bommert (11 shared papers)Bernd Dörken (8 shared papers)Torsten Steinbrunn (11 shared papers)Mindaugas Andrulis (6 shared papers)Pia Herrmann (4 shared papers)
Journals: Blood (20 papers)British Journal of Haematology (6 papers)Leukemia (4 papers)Journal of Clinical Oncology (4 papers)Haematologica (3 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Manik Chatterjee

84 papers receiving 2.7k citations

Peers

Countries citing papers authored by Manik Chatterjee

Since Specialization

Citations

This map shows the geographic impact of Manik Chatterjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manik Chatterjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manik Chatterjee more than expected).

Fields of papers citing papers by Manik Chatterjee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manik Chatterjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manik Chatterjee. The network helps show where Manik Chatterjee may publish in the future.

Co-authors

The 25 scholars most cited alongside Manik Chatterjee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Manik Chatterjee Line = papers co-authored together Manik Chatterjee links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells Blood ·Franziska Jundt, Kristina Schulze Pröbsting, Ioannis Anagnostopoulos, Gwendolin Muehlinghaus, Manik Chatterjee, Stephan Mathas, Ralf C. Bargou, Rudolf A. Manz, Harald Stein, Bernd Dörken	2004	171
2	Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma Blood ·Thorsten Stühmer, Manik Chatterjee, Martin Hildebrandt, Pia Herrmann, Hella Gollasch, Christian Gerecke, Sebastian Theurich, Luisa Cigliano, Rudolf A. Manz, Peter T. Daniel, Kurt Bommert, Lyubomir T. Vassilev, Ralf C. Bargou	2005	140
3	The PI3K/Akt signaling pathway regulates the expression of Hsp70, which critically contributes to Hsp90-chaperone function and tumor cell survival in multiple myeloma Haematologica ·Manik Chatterjee, Mindaugas Andrulis, Thorsten Stühmer, Elisabeth Müller, Claudia Hofmann, Torsten Steinbrunn, Tracey Heimberger, Heike Schraud, S. Kressmann, Hermann Einsele, Ralf C. Bargou	2012	132
4	STAT3 and MAPK signaling maintain overexpression of heat shock proteins 90α and β in multiple myeloma cells, which critically contribute to tumor-cell survival Blood ·Manik Chatterjee, Sarika Jain, Thorsten Stühmer, Mindaugas Andrulis, Ute Ungethüm, Ralf‐Jürgen Kuban, Heike Lorentz, Kurt Bommert, Max S. Topp, Doris Krämer, Hans Konrad Müller‐Hermelink, Hermann Einsele, Andreas Greiner, Ralf C. Bargou	2006	124
5	Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells Blood ·Manik Chatterjee, Thorsten Stühmer, Pia Herrmann, Kurt Bommert, Bernd Dörken, Ralf C. Bargou	2004	110
6	PI3-K/AKT/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells Leukemia ·Suzanne Lentzsch, Manik Chatterjee, Margarete Gries, Kurt Bommert, Hella Gollasch, Bernd Dörken, Ralf C. Bargou	2004	100
7	The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma Blood ·Manik Chatterjee, Christoph Rancsó, Thorsten Stühmer, Niels Eckstein, Mindaugas Andrulis, Christian Gerecke, Heike Lorentz, Hans‐Dieter Royer, Ralf C. Bargou	2007	95
8	In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway Blood ·Manik Chatterjee, Dirk Hönemann, Suzanne Lentzsch, Kurt Bommert, Christine Sers, Pia Herrmann, Stephan Mathas, Bernd Dörken, Ralf C. Bargou	2002	77
9	Novel HSP90 inhibitors, NVP-AUY922 and NVP-BEP800, radiosensitise tumour cells through cell-cycle impairment, increased DNA damage and repair protraction British Journal of Cancer ·Lavinia Stingl, Thorsten Stühmer, Manik Chatterjee, Michael Rugaard Jensen, Michael Flentje, Cholpon S. Djuzenova	2010	74
10	Mutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survival Blood ·Torsten Steinbrunn, Thorsten Stühmer, Stefan Gattenlöhner, Andreas Rosenwald, Anja Mottok, Christian Unzicker, Hermann Einsele, Manik Chatterjee, Ralf C. Bargou	2010	69
11	MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1–2a trial The Lancet Haematology ·Marc S. Raab, Monika Engelhardt, Antje Blank, Hartmut Goldschmidt, Hermine Agis, Igor Wolfgang Blau, Hermann Einsele, Barbara Ferstl, Natalie Schub, Christoph Röllig, Katja Weisel, Mark Winderlich, Janine Griese, Stefan Härtle, Johannes Weirather, Tiantom Jarutat, Christian Peschel, Manik Chatterjee	2020	68
12	Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma Leukemia ·Thorsten Stühmer, Angela Zöllinger, Daniela Siegmund, Manik Chatterjee, Evelyn Grella, Stefan Knop, K. Martin Kortüm, Christian Unzicker, Michael Rugaard Jensen, Cornelia Quadt, Patrick Chêne, Joseph Schoepfer, Carlos Garcı́a-Echeverrı́a, Hermann Einsele, Harald Wajant, Ralf C. Bargou	2008	67
13	GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6 Haematologica ·Leo Rasche, Johannes Duell, Inês C. Castro, Valentina Dubljevic, Manik Chatterjee, Stefan Knop, Frank Hensel, Andreas Rosenwald, Hermann Einsele, Max S. Topp, Stephanie Brändlein	2015	67
14	Long-term outcome of patients with relapsed/refractory B-cell non-Hodgkin lymphoma treated with blinatumomab Blood Advances ·Vera Dufner, Cyrus Sayehli, Manik Chatterjee, Horst Hummel, Götz Gelbrich, Ralf C. Bargou, Maria-Elisabeth Goebeler	2019	65
15	Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells Oncogene ·Unn-Merethe Fagerli, Katrin Ullrich, Thorsten Stühmer, Toril Holien, Karl Köchert, Randi Utne Holt, Øyvind S. Bruland, Manik Chatterjee, Hendrik Nogai, Georg Lenz, John D. Shaughnessy, Stephan Mathas, Anders Sundan, Ralf C. Bargou, Bernd Dörken, Magne Børset, Martin Janz	2011	63
16	Combined functional and molecular analysis of tumor cell signaling defines 2 distinct myeloma subgroups: Akt-dependent and Akt-independent multiple myeloma Blood ·Angela Zöllinger, Thorsten Stühmer, Manik Chatterjee, Stefan Gattenlöhner, Eugenia Haralambieva, Hans–Konrad Müller–Hermelink, Mindaugas Andrulis, Andreas Greiner, Carmen Wesemeier, Jörg C. Rath, Hermann Einsele, Ralf C. Bargou	2008	60
17	CXCL12 and CXCR7 are relevant targets to reverse cell adhesion‐mediated drug resistance in multiple myeloma British Journal of Haematology ·Johannes M. Waldschmidt, Anna Simon, Dagmar Wider, Stefan J. Müller, Marie Follo, Gabriele Ihorst, Sarah Decker, Joschka Lorenz, Manik Chatterjee, Abdel Kareem Azab, Justus Duyster, Ralph Wäsch, Monika Engelhardt	2017	59
18	Dioncophyllines C₂, D₂, and F and Related Naphthylisoquinoline Alkaloids from the Congolese Liana Ancistrocladus ileboensis with Potent Activities against Plasmodium falciparum and against Multiple Myeloma and Leukemia Cell Lines Journal of Natural Products ·Jun Li, Raina Seupel, Doris Feineis, Virima Mudogo, Marcel Kaiser, Reto Brun, Daniela Brünnert, Manik Chatterjee, Ean‐Jeong Seo, Thomas Efferth, Gerhard Bringmann	2017	59
19	The Natural Human IgM Antibody PAT-SM6 Induces Apoptosis in Primary Human Multiple Myeloma Cells by Targeting Heat Shock Protein GRP78 PLoS ONE ·Leo Rasche, Johannes Duell, Charlotte Morgner, Manik Chatterjee, Frank Hensel, Andreas Rosenwald, Hermann Einsele, Max S. Topp, Stephanie Brändlein	2013	55
20	The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma British Journal of Haematology ·Tanja Heimberger, Mindaugas Andrulis, Simone S. Riedel, Thorsten Stühmer, Heike Schraud, Andreas Beilhack, Thomas G.P. Bumm, Bjarne Bogen, Hermann Einsele, Ralf C. Bargou, Manik Chatterjee	2012	54

About Manik Chatterjee

Manik Chatterjee is a scholar working on Hematology, Oncology, Immunology, Molecular Biology and Toxicology, having authored 87 papers that have together received 2.7k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (38 papers), Protein Degradation and Inhibitors (12 papers), Heat shock proteins research (12 papers), Cancer Mechanisms and Therapy (9 papers), Toxin Mechanisms and Immunotoxins (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Peptidase Inhibition and Analysis (6 papers). The work is most often cited by research in Hematology (880 citations), Oncology (844 citations), Molecular Biology (1.7k citations), Immunology (424 citations) and Genetics (167 citations). Manik Chatterjee has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Ralf C. Bargou, Thorsten Stühmer, Hermann Einsele, Kurt Bommert, Bernd Dörken, Torsten Steinbrunn, Mindaugas Andrulis, Pia Herrmann, Andreas Rosenwald and Stephan Mathas. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, Journal of Clinical Oncology and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact